- Home
- EXR vs TAK Comparison
EXR vs TAK Comparison
Compare EXR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXR
- TAK
- Stock Information
- Founded
- EXR 1977
- TAK 1781
- Country
- EXR United States
- TAK Japan
- Employees
- EXR N/A
- TAK N/A
- Industry
- EXR Real Estate Investment Trusts
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- EXR Real Estate
- TAK Health Care
- Exchange
- EXR Nasdaq
- TAK Nasdaq
- Market Cap
- EXR 36.2B
- TAK 41.5B
- IPO Year
- EXR 2004
- TAK N/A
- Fundamental
- Price
- EXR $147.05
- TAK $13.10
- Analyst Decision
- EXR Hold
- TAK
- Analyst Count
- EXR 14
- TAK 0
- Target Price
- EXR $171.43
- TAK N/A
- AVG Volume (30 Days)
- EXR 1.0M
- TAK 1.6M
- Earning Date
- EXR 10-29-2024
- TAK 01-30-2025
- Dividend Yield
- EXR 4.41%
- TAK 4.84%
- EPS Growth
- EXR N/A
- TAK 49.73
- EPS
- EXR 3.81
- TAK 1.27
- Revenue
- EXR $3,311,251,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- EXR N/A
- TAK $4.41
- Revenue Next Year
- EXR $2.35
- TAK $1.09
- P/E Ratio
- EXR $38.57
- TAK $20.56
- Revenue Growth
- EXR 42.80
- TAK 9.43
- 52 Week Low
- EXR $131.02
- TAK $12.58
- 52 Week High
- EXR $184.87
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- EXR 29.30
- TAK 36.45
- Support Level
- EXR $142.09
- TAK $12.98
- Resistance Level
- EXR $165.54
- TAK $13.42
- Average True Range (ATR)
- EXR 3.80
- TAK 0.15
- MACD
- EXR -1.98
- TAK -0.05
- Stochastic Oscillator
- EXR 17.45
- TAK 10.85
About EXR Extra Space Storage Inc
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 3,800 self-storage properties in 42 states, with over 285 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.